亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Enterically delivered alginates as prebiotics

技術優勢
Commonly consumed food ingredient with good safety profile Inexpensive in comparison to may current cancer treatments May reduce the progression of polyps to cancer
詳細技術說明
Epidemiological, animal and cellular evidence supports the hypothesis that iron metabolism plays a central role in the causation of cancer. In particular workers at the University have previously reported that the main proteins implicated in cellular iron transport are modulated during carcinogenesis, notably in colorectal cancer, and that this may promote the development and progression of cancer. Recent work using animal models of colorectal cancer has shown that it is specifically the levels of iron in the intestinal lumen of the colon that is important in promoting cancer rather than systemic levels of iron. This is important as it suggests that a therapeutic strategy to ΓÇ£mop upΓÇØ iron in the colon could be effective at reducing colorectal cancer without the need to induce systemic anaemia. The targeted delivery of chelators such as sodium alginate to the colon offers a real prospect of improving the outcome for colorectal cancer patients
*Abstract
Around 1 in 20 people in the UK will develop colorectal cancer during their lifetime. There is a significant body of epidemiological, animal and cellular evidence that iron metabolism plays a central role in the cause of cancer
*Principal Investigation

Name: Dr. Chris Tselepis

Department:

附加資料
Inventor: TSELEPIS, Chris | IQBAL, Tariq
Priority Number: WO2011051665A1
IPC Current: A61K0031715 | A61P003500
Assignee Applicant: The University of Birmingham
Title: ANTI-CANCER COMPOSITION COMPRISING ALGINATE | COMPOSITION ANTICANCÉREUSE COMPRENANT DE L'ALGINATE
Usefulness: ANTI-CANCER COMPOSITION COMPRISING ALGINATE | COMPOSITION ANTICANCÉREUSE COMPRENANT DE L'ALGINATE
Summary: For the prophylaxis and/or treatment of colorectal cancer in a mammal; and for the selective targeting of the iron chelator to the colon (claimed).
Novelty: Composition useful for prophylaxis and treatment of colorectal cancer in a mammal, and for selective targeting of iron chelator to the colon comprises an iron chelator
主要類別
診斷/治療
細分類別
癌症/腫瘤
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備